Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 4 | Vintage Vibes

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’

The Guardian - UK

Millions of doses of ‘pandemic-ending’ HIV jab at risk over Trump’s aid cuts

INTERVIEW: The funding for 2 million people to receive the twice-yearly preventative treatment lenacapavir is ‘receding in the chaos’ of the US president’s decision, the doctor behind the trial of the drug tells Rachel Schraer

The Independent UK

'The Handmaid's Tale's Ending Brought The Show Back To Its Worst Habits

The series finally ended, but not without going back to its most annoying trope.

Inverse

From analysis to the latest developments in health,
read the most diverse news in one place.

Unusual Options Alert: The Smart Money is Piling Into Gilead Sciences (GILD)

While the new political paradigm might not be the most conducive environment for Gilead Sciences, positive sentiment is brewing for GILD stock.

Barchart

Handmaid’s Tale star breaks down episode 1’s shock reunion

Emotional scene is part of how the show will end

The Independent UK

3 Biotech Giants Gaining From U.S. Sales and Policy Shifts

The significant domestic revenue base of select US biotech companies offers stability potential for investors navigating global trade complexities.

MarketBeat

Why does Serena wear pink in The Handmaid's Tale season 6?

There's a status and outfit change for one of Gilead's most feared former Wives in season 6

Woman & Home

Read news from The Economist, FT, and more,
with one subscription

Doctors Pushed HIV Meds On Patients in Exchange For Lavish Meals, Trips, and Cash: Prosecutors

A pharmaceutical company that paid doctors kickbacks to push their HIV/AIDS drugs has agreed to pay a fine of more than $200 million.

Medical Daily

Does Janine die in The Handmaid's Tale?

She's been through so much and had quite the journey throughout each series of The Handmaid's Tale - and fans want to know the fate of Janine

Woman & Home

6 new movies and shows to watch this weekend on Netflix, Prime, Disney Plus, and more (April 18 - 20)

The Last of Us season 2 and award-winning movie Conclave are among this week's best streaming releases

Total Film

Where is New Bethlehem in The Handmaid's Tale? The fictional place and real-life filming locations explored

New Bethlehem features a lot in season 6 of The Handmaid's Tale - we reveal where it could sit within the show's geography as well as the real-life filming location.

Woman & Home

Here's What to Expect From Gilead Sciences’ Next Earnings Report

Gilead Sciences is expected to announce its fiscal first-quarter earnings this month, and analysts forecast a robust triple-digit in its earnings.

Barchart

Handmaid’s Tale fans ‘cannot believe’ ending of first episode of season six: ‘It was worth the wait’

Hulu’s hit dystopian show is airing its final season in the U.S.

The Independent UK

10 top new movies and shows to stream this weekend on Netflix, Max and more (April 11-13)

'The White Lotus' finale, 'Dying for Sex' and 'Black Bag' lead my weekend watch list

Tom’s Guide

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

"The Handmaid's Tale": America's finale

We've watched June run in and out of Gilead and now we're running with her

Evening Standard

The Handmaid’s Tale season 6: UK release date, cast, plot and how to watch

Fans can expect the final instalment to deliver the ultimate showdown between the rebels, led by Elizabeth Moss’s June, and Gilead

The Independent UK

Praise be, loyal ‘Handmaid’s Tale’ fans: Propulsive final season promises a satisfying catharsis

Praise be

Inverse

'The Handmaid's Tale' Season 6 Review: Hulu's Brutal Dystopian Show Finally Gets An Ending

After eight years of fascist dystopia, June Osborne finally gets to rest.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating

JPMorgan's upgrade on Gilead sparks bullish sentiment for the healthcare sector—here's why stocks like Pfizer and Hims & Hers are promising opportunities.

Barchart

These 2 Buy-Rated Dividend Stocks Could Be Next in Line for a Trump Tariff Selloff. Should You Jump Ship Now?

Trump’s proposed tariffs on pharmaceutical imports from countries like Ireland and India have sparked concerns for companies like Amgen and Gilead Sciences.

Euronews

UNAIDS chief urges Donald Trump to make an 'amazing deal' to end HIV

The UNAIDS director also warned that US funding cuts could be dire for global efforts to curb HIV.

Radio France Internationale

AIDS pandemic risks 'resurging globally' amid US funding halt: UN

The world risks returning to the worst days of the global AIDS pandemic following the sudden halt to US foreign aid funding, the UN's top AIDS official said Monday, warning millions would die.

The Independent UK

UNAIDS director proposes that President Trump make an 'amazing deal' to end HIV

The head of the U.N. AIDS agency says the sudden loss of American money has been “devastating” for efforts to stop HIV and will cost many lives of the world’s most vulnerable people

Barchart

Gilead Sciences - Leader in HIV Medicines

Summary Gilead Sciences (GILD) shows strong technical buy signals, with a 19.60% gain since Trend Seeker's buy signal on 1/27 and a 50.31% gain in the last year. The company offers a diverse portfolio of medicines for HIV, COVID-19, liver diseases, oncology, and more, with significant collaborations enhancing its pipeline....

Barchart

How Is Gilead Sciences' Stock Performance Compared to Other Pharmaceutical Stocks?

As Gilead Sciences has outperformed its industry peers recently, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.